Year in Review: Clinical Investigator Perspectives on the Most Relevant New Data Sets and Advances in HER2-Positive and Triple-Negative Breast Cancer
15th March 2024 • Oncology Today with Dr Neil Love • Research To Practice
00:00:00
01:05:46